[Company Logo Image] Compound validation and profiling in vitro and in vivo
Improved clinical predictability of preclinical studies
Subcutaneous and orthotopic human xenografts
Genetically modified organ specific tumour models
Receptor tyrosine kinase-driven breast cancer model

         Preclinical Concept Validation

Angiogenesis in vivo Model


Syngeneic tumour models
Pharmacokinetic studies
  Toxicology (GLP)
  Histology (Frozen Sections and Paraffin Embedded Sections)


Home Up vivoPharm Search Employment Feedback

Up Histology 1 Histology 2


Genetically Modified Mammary Gland (GeMag)

Syngeneic breast epithelial cells were infected with NeuT (erbB-2). Histology was taken after 6 weeks of tumour development

Intraepithelial neoplasia with cysts


Send mail to webmaster@vivopharm.com with questions or comments about this web site.
Last modified: 18-Dec-2003